News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
625,159 Results
Type
Article (48029)
Company Profile (218)
Press Release (576912)
Section
Business (177490)
Career Advice (2595)
Deals (32666)
Drug Delivery (123)
Drug Development (79152)
Employer Resources (164)
FDA (16335)
Job Trends (13663)
News (314318)
Policy (32527)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (3)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2425)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (79)
Alliances (44932)
ALS (89)
Alzheimer's disease (1448)
Antibody-drug conjugate (ADC) (135)
Approvals (16304)
Artificial intelligence (254)
Autoimmune disease (23)
Automation (10)
Bankruptcy (328)
Best Places to Work (10205)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (113)
Bladder cancer (64)
Brain cancer (28)
Breast cancer (254)
Cancer (2034)
Cardiovascular disease (177)
Career advice (2163)
Career pathing (33)
CAR-T (145)
Cell therapy (417)
Cervical cancer (19)
Clinical research (64277)
Collaboration (752)
Compensation (492)
Complete response letters (29)
COVID-19 (2665)
CRISPR (40)
C-suite (213)
Cystic fibrosis (96)
Data (1939)
Decentralized trials (2)
Denatured (27)
Depression (49)
Diabetes (260)
Diagnostics (5638)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (113)
Drug pricing (120)
Drug shortages (32)
Duchenne muscular dystrophy (90)
Earnings (70211)
Editorial (40)
Employer branding (20)
Employer resources (146)
Events (94776)
Executive appointments (645)
FDA (17482)
Featured Employer (42)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (642)
Gene editing (100)
Generative AI (24)
Gene therapy (304)
GLP-1 (799)
Government (4035)
Grass and pollen (5)
Guidances (46)
Healthcare (16053)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (127)
Indications (26)
Infectious disease (2810)
Inflammatory bowel disease (137)
Inflation Reduction Act (9)
Influenza (50)
Intellectual property (86)
Interviews (475)
IPO (15358)
IRA (49)
Job creations (3863)
Job search strategy (1816)
Kidney cancer (10)
Labor market (31)
Layoffs (513)
Leadership (21)
Legal (7882)
Liver cancer (73)
Lung cancer (299)
Lymphoma (137)
Machine learning (4)
Management (58)
Manufacturing (292)
MASH (68)
Medical device (11584)
Medtech (11588)
Mergers & acquisitions (17797)
Metabolic disorders (720)
Multiple sclerosis (78)
NASH (23)
Neurodegenerative disease (97)
Neuropsychiatric disorders (31)
Neuroscience (1978)
NextGen: Class of 2025 (5536)
Non-profit (3438)
Northern California (2376)
Now hiring (27)
Obesity (398)
Opinion (256)
Ovarian cancer (67)
Pain (84)
Pancreatic cancer (75)
Parkinson's disease (148)
Partnered (17)
Patents (212)
Patient recruitment (95)
Peanut (46)
People (52378)
Pharmaceutical (90)
Pharmacy benefit managers (21)
Phase I (19804)
Phase II (27924)
Phase III (21772)
Pipeline (1099)
Podcasts (104)
Policy (140)
Postmarket research (2611)
Preclinical (8023)
Press Release (50)
Prostate cancer (97)
Psychedelics (37)
Radiopharmaceuticals (242)
Rare diseases (391)
Real estate (5414)
Recruiting (65)
Regulatory (22712)
Reports (35)
Research institute (2231)
Resumes & cover letters (427)
Rett syndrome (4)
RNA editing (4)
RSV (44)
Schizophrenia (77)
Series A (122)
Series B (77)
Service/supplier (14)
Sickle cell disease (55)
Southern California (2040)
Special edition (18)
Spinal muscular atrophy (154)
Sponsored (32)
Startups (3337)
State (2)
Stomach cancer (16)
Supply chain (68)
Tariffs (15)
The Weekly (75)
United States (20458)
Vaccines (749)
Venture capitalists (38)
Webinars (13)
Weight loss (293)
Women's health (34)
Worklife (19)
Date
Today (103)
Last 7 days (521)
Last 30 days (2585)
Last 365 days (32361)
2025 (8499)
2024 (33912)
2023 (37973)
2022 (48622)
2021 (52398)
2020 (49774)
2019 (40611)
2018 (31005)
2017 (31309)
2016 (30111)
2015 (33776)
2014 (27447)
2013 (23079)
2012 (24736)
2011 (25346)
2010 (23294)
Location
Africa (789)
Alabama (42)
Alaska (7)
Arizona (185)
Arkansas (12)
Asia (38995)
Australia (6468)
California (5355)
Canada (1664)
China (462)
Colorado (242)
Connecticut (270)
Delaware (133)
Europe (87934)
Florida (813)
Georgia (177)
Hawaii (1)
Idaho (44)
Illinois (460)
India (25)
Indiana (257)
Iowa (9)
Japan (146)
Kansas (87)
Kentucky (21)
Louisiana (8)
Maine (64)
Maryland (833)
Massachusetts (4147)
Michigan (180)
Minnesota (335)
Mississippi (1)
Missouri (66)
Montana (18)
Nebraska (22)
Nevada (53)
New Hampshire (53)
New Jersey (1562)
New Mexico (26)
New York (1513)
North Carolina (926)
North Dakota (6)
Northern California (2376)
Ohio (163)
Oklahoma (10)
Oregon (32)
Pennsylvania (1176)
Puerto Rico (10)
Rhode Island (23)
South America (1164)
South Carolina (16)
South Dakota (1)
Southern California (2040)
Tennessee (86)
Texas (774)
Utah (144)
Virginia (129)
Washington D.C. (61)
Washington State (505)
West Virginia (3)
Wisconsin (51)
625,159 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Resolutions from Zealand Pharma’s Annual General Meeting 2025
March 28, 2025
·
5 min read
Press Releases
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
March 21, 2025
·
2 min read
Press Releases
Zealand Pharma convenes its Annual General Meeting 2025
February 20, 2025
·
1 min read
Press Releases
Zealand Pharma Announces Financial Results for the Full Year 2024
February 20, 2025
·
11 min read
Weight loss
Roche Makes Another Obesity Play With Potential $5.3B Amylin Pact With Zealand
Roche and Zealand plan to study petrelintide as a monotherapy and in combination with CT-388, a dual agonist of the GLP-1 and GIP receptors that Roche picked up in its recent acquisition of Carmot Therapeutics.
March 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
February 20, 2025
·
11 min read
Press Releases
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
March 17, 2025
·
8 min read
Press Releases
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity
March 12, 2025
·
13 min read
Complete response letters
Zealand Hit With CRL for Ultrarare Genetic Disease Treatment
The rejection is related to the timing of the FDA’s reinspection of Zealand’s third-party manufacturer, which previously had deficiencies.
October 9, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity
March 12, 2025
·
9 min read
1 of 62,516
Next
